Obesity Clinical Trial
— C3POOfficial title:
Coordinating Pragmatic Primary Care Population Management for Obesity
Verified date | January 2022 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The C3PO pilot and feasibility study uses a rigorous, mixed-method research design to provide information needed to refine and implement a technology-mediated primary care outreach intervention approach before conducting a larger and more definitive future intervention trial.
Status | Completed |
Enrollment | 80 |
Est. completion date | June 30, 2021 |
Est. primary completion date | June 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - BMI = 27 kg/m2 - = 1 CVD risk condition (hypertension, dyslipidemia, prediabetes or type 2 diabetes) - Registered in Northwestern Medical Group's EpicCare MyChart patient portal - Received and completed MyChart survey of weight loss interest - Affirms interest in weight loss goal setting and receiving additional resource information and electronic Scale. Exclusion Criteria: - Evidence of hospitalization in past 30 days - Most recent blood pressure >180/105 - Cancer (non-skin) treatment within the past 2 years - Encounter diagnosis for hypoglycemia in past 30 days - Actively receiving care from the bariatric surgery service or a bariatric medication order in the past 100 days |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern Medicine | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Who Achieved 5% Weight Loss Goal at 6 Months | Proportion of Participants who Reach a 5% Weight Loss Goal at 6 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 6 months (kg))/(Baseline body mass (kg)) | Baseline - 6 Months | |
Secondary | Costs to Implement the Intervention | Costs (US$) of Intervention Components, including the costs to fund personnel efforts, technology, and other intervention components | Baseline - 12 Months | |
Secondary | Change in Hemoglobin A1C | Mean change in Hemoglobin A1C levels (DCCT%) from baseline to 12 months | Baseline - 12 Months | |
Secondary | Change in Systolic Blood Pressure | Mean change in systolic blood pressure (mmHg) from baseline to 12 months | Baseline - 12 Months | |
Secondary | Change in Total Cholesterol | Mean change in total cholesterol concentration (mg/dL) from baseline to 12 months | Baseline - 12 Months | |
Secondary | Change in Non-HDL Cholesterol | Mean change in non-HDL cholesterol concentration (mg/dL) from baseline to 12 months | Baseline - 12 Months | |
Secondary | Body Mass Change at 6 Months | Mean Change in Body Mass (kg) from Baseline to 6 Months | Baseline - 6 Months | |
Secondary | Body Mass Change at 12 Months | Mean Change in Body Mass (kg) from Baseline to 12 Months | Baseline - 12 Months | |
Secondary | Number of Participants Who Achieved 5% Weight Loss Goal in 12 Months | Proportion of Participants who Reach a 5% Weight Loss Goal at 12 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 12 months (kg))/(Baseline body mass (kg)) | Baseline - 12 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |